Pluvicto
UK grants early access to Novartis’ prostate cancer radioligand
Phil Taylor
Advanced Accelerator Applications, Early Access to Medicines Scheme, MHRA, Novartis, Pluvicto, Prostate cancer, Radiopharmaceutical, UK
0 Comment
X
UK grants early access to Novartis’ prostate cancer radioligand
https://pharmaphorum.com/news/uk-grants-early-access-to-novartis-prostate-cancer-radioligand/
Novartis gets first OK for radioligand Pluvicto in prostate cancer
Phil Taylor
Novartis, Oncology, Pluvicto, Prostate cancer, Radiopharmaceutical, regulatory approval
0 Comment
X
Novartis gets first OK for radioligand Pluvicto in prostate cancer
https://pharmaphorum.com/news/novartis-gets-first-ok-for-radioligand-pluvicto-in-prostate-cancer/